Omnicell Inc (OMCL)
Working capital turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,112,240 | 1,147,110 | 1,295,950 | 1,132,020 | 892,208 |
| Total current assets | US$ in thousands | 815,493 | 927,571 | 881,812 | 780,702 | 829,414 |
| Total current liabilities | US$ in thousands | 595,678 | 367,792 | 428,446 | 876,158 | 276,423 |
| Working capital turnover | 5.06 | 2.05 | 2.86 | — | 1.61 |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $1,112,240K ÷ ($815,493K – $595,678K)
= 5.06
Omnicell Inc's working capital turnover has shown a fluctuating trend over the past few years. In 2020, the working capital turnover ratio stood at 1.61, indicating that the company generated $1.61 in sales for every dollar of working capital invested. In 2021, the ratio is missing, which could suggest a lack of data or a significant change in the company's operations.
However, in 2022, Omnicell's working capital turnover significantly improved to 2.86, signaling a more efficient utilization of working capital to drive sales. This improvement may indicate better inventory management or tighter control over receivables and payables.
By 2023, the ratio dipped to 2.05, but remained relatively healthy, indicating that the company was still effectively leveraging its working capital to generate revenue. Finally, in 2024, the working capital turnover ratio soared to 5.06, signaling a substantial increase in efficiency and a strong ability to convert working capital into sales.
Overall, Omnicell's working capital turnover ratios demonstrate varying levels of efficiency in utilizing its working capital to drive sales over the years, with notable improvements in certain periods and a gap in available data for 2021.
Peer comparison
Dec 31, 2024